gurinder singh, Royal Manchester Children Hospital.Manchester
23 December 2007
Although Scientific facts differ from the parents's belief but results of this study are not surprising.Considering the fact that use of
antipsychotic treatment is associated with metabolic side effects that include various degrees of weight gain, dyslipidemia,
susceptibility to type 2 diabetes,it is natural for parents to consider psychotherapy as first choice of treatment.These adverse
effects associated with second-generation antipsychotics are also part of the metabolic syndrome, which has been associated with higher morbidity and mortality from cardiovascular disorders .Using presence of abdominal obesity and/or elevated fasting blood glucose may identify 100% of the patients with the metabolic syndrome. To change the belief of parents and patients we need to incorporate monitoring and dealing for metabloic effects protocols into our practice. Its the only way to ensure parents about safety in the use of Psychotrpic medication.
Annals of General Psychiatry
Reasons for parents concern about Psychotropics
23 December 2007
Although Scientific facts differ from the parents's belief but results of this study are not surprising.Considering the fact that use of
antipsychotic treatment is associated with metabolic side effects that include various degrees of weight gain, dyslipidemia,
susceptibility to type 2 diabetes,it is natural for parents to consider psychotherapy as first choice of treatment.These adverse
effects associated with second-generation antipsychotics are also part of the metabolic syndrome, which has been associated with higher morbidity and mortality from cardiovascular disorders .Using presence of abdominal obesity and/or elevated fasting blood glucose may identify 100% of the patients with the metabolic syndrome. To change the belief of parents and patients we need to incorporate monitoring and dealing for metabloic effects protocols into our practice. Its the only way to ensure parents about safety in the use of Psychotrpic medication.
Competing interests
None declared